Genpharmasec has informed that in continuation of the outcome of financial results submitted by the company on 11th November, 2022 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting Conclusion time was inadvertently not mentioned. The company submitted a revised outcome of Board Meeting for approval of Financial results having the required information the Conclusion Time as specified to be given under SEBI Circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015, and there is no change in any financial figures.
The above information is a part of company’s filings submitted to BSE.
